Analysis of ion transport in the airway epithelium using RNA interference

Raffaella Melani, Luis J V Galietta, Olga Zegarra Moran

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Knowledge of the physiology of airway epithelium had been limited by the lack of potent and selective inhibitors of the ion channels, transporters and regulators involved in transepithelial electrolyte and fluid transport. The use of siRNA technology to downregulate the expression of a given gene represents a useful method for studying the function of proteins in both native cells and tissues, enabling a more precise assessment of the contribution of single proteins to the general transport process in the airway epithelium and an evaluation of the contribution of these proteins in various respiratory conditions. This review focuses on recent research involving siRNA-based silencing of proteins implicated in ion transport through the airway epithelium, illustrating how this technology has increased our understanding of the function and regulation of the transport pathway, and has helped to identify new targets for drugs and to uncover the function of newly identified proteins.

Original languageEnglish
Pages (from-to)282-291
Number of pages10
JournalCurrent Opinion in Molecular Therapeutics
Volume11
Issue number3
Publication statusPublished - Jun 2009

Fingerprint

Ion Transport
RNA Interference
Epithelium
Proteins
Small Interfering RNA
Technology
Ion Channels
Electrolytes
Down-Regulation
Research
Pharmaceutical Preparations
Genes

Keywords

  • Airway
  • Ion channel
  • siRNA
  • Transepithelial transport

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Molecular Medicine
  • Genetics(clinical)
  • Drug Discovery
  • Pharmacology

Cite this

Analysis of ion transport in the airway epithelium using RNA interference. / Melani, Raffaella; Galietta, Luis J V; Moran, Olga Zegarra.

In: Current Opinion in Molecular Therapeutics, Vol. 11, No. 3, 06.2009, p. 282-291.

Research output: Contribution to journalArticle

@article{05c97bb3fd0e45798858b7573cea6237,
title = "Analysis of ion transport in the airway epithelium using RNA interference",
abstract = "Knowledge of the physiology of airway epithelium had been limited by the lack of potent and selective inhibitors of the ion channels, transporters and regulators involved in transepithelial electrolyte and fluid transport. The use of siRNA technology to downregulate the expression of a given gene represents a useful method for studying the function of proteins in both native cells and tissues, enabling a more precise assessment of the contribution of single proteins to the general transport process in the airway epithelium and an evaluation of the contribution of these proteins in various respiratory conditions. This review focuses on recent research involving siRNA-based silencing of proteins implicated in ion transport through the airway epithelium, illustrating how this technology has increased our understanding of the function and regulation of the transport pathway, and has helped to identify new targets for drugs and to uncover the function of newly identified proteins.",
keywords = "Airway, Ion channel, siRNA, Transepithelial transport",
author = "Raffaella Melani and Galietta, {Luis J V} and Moran, {Olga Zegarra}",
year = "2009",
month = "6",
language = "English",
volume = "11",
pages = "282--291",
journal = "Current Opinion in Molecular Therapeutics",
issn = "1464-8431",
publisher = "Current Drugs Ltd.",
number = "3",

}

TY - JOUR

T1 - Analysis of ion transport in the airway epithelium using RNA interference

AU - Melani, Raffaella

AU - Galietta, Luis J V

AU - Moran, Olga Zegarra

PY - 2009/6

Y1 - 2009/6

N2 - Knowledge of the physiology of airway epithelium had been limited by the lack of potent and selective inhibitors of the ion channels, transporters and regulators involved in transepithelial electrolyte and fluid transport. The use of siRNA technology to downregulate the expression of a given gene represents a useful method for studying the function of proteins in both native cells and tissues, enabling a more precise assessment of the contribution of single proteins to the general transport process in the airway epithelium and an evaluation of the contribution of these proteins in various respiratory conditions. This review focuses on recent research involving siRNA-based silencing of proteins implicated in ion transport through the airway epithelium, illustrating how this technology has increased our understanding of the function and regulation of the transport pathway, and has helped to identify new targets for drugs and to uncover the function of newly identified proteins.

AB - Knowledge of the physiology of airway epithelium had been limited by the lack of potent and selective inhibitors of the ion channels, transporters and regulators involved in transepithelial electrolyte and fluid transport. The use of siRNA technology to downregulate the expression of a given gene represents a useful method for studying the function of proteins in both native cells and tissues, enabling a more precise assessment of the contribution of single proteins to the general transport process in the airway epithelium and an evaluation of the contribution of these proteins in various respiratory conditions. This review focuses on recent research involving siRNA-based silencing of proteins implicated in ion transport through the airway epithelium, illustrating how this technology has increased our understanding of the function and regulation of the transport pathway, and has helped to identify new targets for drugs and to uncover the function of newly identified proteins.

KW - Airway

KW - Ion channel

KW - siRNA

KW - Transepithelial transport

UR - http://www.scopus.com/inward/record.url?scp=67650266857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650266857&partnerID=8YFLogxK

M3 - Article

C2 - 19479661

AN - SCOPUS:67650266857

VL - 11

SP - 282

EP - 291

JO - Current Opinion in Molecular Therapeutics

JF - Current Opinion in Molecular Therapeutics

SN - 1464-8431

IS - 3

ER -